| CAS NO: | 2023788-19-2 |
| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 生物活性 | Tirzepatide (LY3298176) is a dualglucose-dependent insulinotropic polypeptide (GIP)andglucagon-like peptide-1 (GLP-1) receptoragonist that is being developed for the treatment of type 2 diabetes[1]. |
| 体内研究 (In Vivo) | Tirzepatide (LY3298176) shows significantly better efficacy with regard to glucose control and weight loss than do Dulaglutide[1]. |
| Clinical Trial | |
| 分子量 | 4813.45 |
| Formula | C225H348N48O68 |
| CAS 号 | 2023788-19-2 |
| Sequence Shortening | Y-{Aib}-EGTFTSDYSI-{Aib}-LDKIAQ-{diacid-gamma-Glu-(AEEA)2-Lys}-AFVQWLIAGGPSSGAPPPS-NH2 |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
